Lessons From Lockdown: Evolving Models of Care for Liver Diseases

In this call between colleagues, expert faculty discuss what they learned during the COVID-19 pandemic about strategies to care for patients with HCV infection, including patients who inject drugs.

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 1, 2021 Expired: No longer available for credit

In this engaging dialogue, 2 expert hepatologists discuss strategies for improving linkage to care of patients with viral hepatitis despite the challenges posed by the COVID-19 pandemic.

Jordan J. Feld, MD, MPH Nancy Reau, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 14, 2022 Expired: March 13, 2023

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining care of patients with hepatocellular carcinoma and patients requiring liver transplantation despite challenges posed by the COVID-19 pandemic.

Graham R. Foster, FRCP, PhD Paul Y. Kwo, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 16, 2022 Expired: March 15, 2023

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and improving care of patients with HBV infection during the COVID-19 pandemic in the US and Asia, with lessons for across the world.

Norah Terrault, MD, MPH Grace LH Wong, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2022 Expired: February 21, 2023

In this engaging dialogue between 2 hepatologists, expert faculty discuss strategies to maintain and improve screening and testing for hepatitis delta virus.

Robert G. Gish, MD Pietro Lampertico, MD, PhD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 7, 2022 Expired: February 6, 2023

Review key slides from liver experts around the globe about lessons learned from the COVID-19 pandemic worth carrying forward.

Gregory Dore, MBBS, PhD, FRACP, MPH Jordan J. Feld, MD, MPH Graham R. Foster, FRCP, PhD Robert G. Gish, MD Paul Y. Kwo, MD Pietro Lampertico, MD, PhD Nancy Reau, MD Norah Terrault, MD, MPH Stacey Trooskin, MD, PhD, MPH Grace LH Wong, MD Released: March 16, 2022

The COVID-19 pandemic has provided the impetus for nimble and creative strategies that meet patients where they are. In the United States, telemedicine visits are one such strategy—and we should carry them forward in the delivery of care.

Stacey Trooskin, MD, PhD, MPH Released: September 29, 2021

Here’s my take on how healthcare developments from the COVID-19 pandemic and simplified HCV screening, treatment, and monitoring can improve management for underserved populations.

Gregory Dore, MBBS, PhD, FRACP, MPH Released: November 8, 2021

As a patient, here are my strategies for maintaining viral hepatitis care and monitoring during the COVID-19 pandemic.

Anonymous Patient Released: February 4, 2022

My thoughts on how to help patients cope with the diagnosis and treatment of hepatitis C and cirrhosis.

Anonymous Patient Released: January 26, 2022

Strategies patients can use to cope with chronic hepatitis B include having frank conversations with healthcare professionals and engaging with patient advocacy groups.

Anonymous Patient Released: February 9, 2022

Learn important data on the interplay of COVID-19 and viral hepatitis–related liver disease, including COVID-19 outcomes in patients with chronic liver disease (CLD) and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.

Robert G. Gish, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: January 10, 2022 Expired: No longer available for credit

Key slides on COVID-19 and viral hepatitis–related chronic liver disease (CLD), including COVID-19 outcomes in patients with CLD and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.

Listen to insights from 2 expert faculty in this dialogue on lessons learned in the care of patients with HCV infection during the COVID-19 pandemic, including patients who inject drugs.

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Released: November 10, 2021

In this engaging dialogue, 2 expert hepatologists discuss strategies for improving linkage to care of patients with viral hepatitis despite the challenges posed by the COVID-19 pandemic.

Jordan J. Feld, MD, MPH Nancy Reau, MD Released: March 14, 2022

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and even improving care of patients with HCC or liver transplantation despite the challenges posed by the COVID-19 pandemic.

Graham R. Foster, FRCP, PhD Paul Y. Kwo, MD Released: March 23, 2022

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and improving care of patients with HBV infection during the COVID-19 pandemic in the United States and Asia, with lessons for around the world.

Norah Terrault, MD, MPH Grace LH Wong, MD Released: February 24, 2022

In this engaging dialogue, 2 expert hepatologists discuss strategies to maintain and improve screening and testing for hepatitis delta virus in the COVID-19 era.

Robert G. Gish, MD Pietro Lampertico, MD, PhD Released: February 11, 2022